Literature DB >> 1974633

Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.

M S Monasky1, A R Zinsmeister, C W Stevens, T L Yaksh.   

Abstract

Physiological data suggest that the direct effect of spinal opiates as well as the activation of adrenergic bulbospinal pathways each results in a reduction in the gain of the stimulus response function in dorsal horn neurons. In its simplest form, this suggests the hypothesis that co-activation of spinal alpha2 and opioid receptors should be manifested as a synergistic interaction in which in its simplest form the net effect would be a product of the effect produced by either drug alone. To assess this hypothesis, rats were prepared with chronically implanted intrathecal (IT) catheters. Dose-response curves for IT morphine were obtained in the presence of fixed doses (0.01 nmol, 0.03 nmol, 0.1 nmol, 0.3 nmol) of 2-[2,6-dimethylphenylamino]-2-imidazoline (ST-91), an alpha 2 agonist. Such concurrent administration of ST-91 resulted in highly significant leftward shifts in the effect of morphine on the hot plate (52.5 degrees C) measure with a significant increase in dose-response curve slopes. To minimize the effects of the cut-off time necessary in an antinociceptive measure, a "Cox proportional hazard" analysis was used. The (log) Hazard function log[h(t)] is expressed as a linear function of the effects resulting from the action of morphine, the action of ST-91 and as a function of an interaction of morphine and ST-91, e.g., the general form is: log[h(t)] = alpha o(t) + beta 1.log doseM + beta 2.log doseST + beta 12.log doseM.log doseST Estimates of the principal coefficients beta 1, beta 2 and beta 12 corresponding to the overall effect of morphine alone, ST-91 alone and the interaction between the two were calculated: beta 1, beta 2 and beta 12. A statistical test of the interaction coefficient revealed that beta 12 was significantly (p less than .001) different from zero, indicating the powerful synergy between IT ST-91 and morphine. Confirmation of the synergistic nature of spinal opioid alpha 2 receptors was provided by the fact that IT injection of naloxone (90 nmol) or phentolamine (100 nmol) after IT injection of various combinations of morphine and ST-91 immediately and completely abolished the potentiating effect of the combination. The clearance of IT [3H]morphine from the thoracic and lumbar spinal cord was not changed in the presence of ST-91. These observations suggest a potent synergistic interaction between spinal mu and alpha 2 adrenergic receptor systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974633

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.

Authors:  L S Stone; L B MacMillan; K F Kitto; L E Limbird; G L Wilcox
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Preweanling naltrindole administration differentially affects clonidine induced antinociception and plasma adrenaline levels in male and female neonatal rats.

Authors:  I Alberti; B Fernández; L F Alguacil; A Aguilar; M Caamaño; E M Romero; M P Viveros
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Altered antinociceptive efficacy of tramadol over time in rats with painful peripheral neuropathy.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

Review 4.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

5.  [Epidural and intrathecal administration of alpha 2-adreno-ceptor agonists for postoperative pain relief].

Authors:  M G Rockemann; W Seeling
Journal:  Schmerz       Date:  1996-04-25       Impact factor: 1.107

6.  The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline.

Authors:  Luc Jasmin; Duc Tien; David Weinshenker; Richard D Palmiter; Paul G Green; Gabriella Janni; Peter T Ohara
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

7.  Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord.

Authors:  Aaron C Overland; Kelley F Kitto; Anne-Julie Chabot-Doré; Patrick E Rothwell; Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

8.  The effect of intrathecal mu, delta, kappa, and alpha-2 agonists on thermal hyperalgesia induced by mild burn on hind paw in rats.

Authors:  Hyun Jung Kim; Tae Kyung Seol; Hee Jong Lee; Tony L Yaksh; Jong Hun Jun
Journal:  J Anesth       Date:  2011-10-09       Impact factor: 2.078

9.  Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn.

Authors:  Maureen S Riedl; Stephen A Schnell; Aaron C Overland; Anne-Julie Chabot-Doré; Anna M Taylor; Alfredo Ribeiro-da-Silva; Robert P Elde; George L Wilcox; Laura S Stone
Journal:  J Comp Neurol       Date:  2009-04-01       Impact factor: 3.215

10.  Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors.

Authors:  Wenling Chen; Bingbing Song; Juan Carlos G Marvizón
Journal:  Neuropharmacology       Date:  2008-02-10       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.